Skip to main content
SpringerLink
Log in

Pharmacotherapy for Children and Adolescents with Conduct Problems

  • Chapter
  • First Online:
Clinical Handbook of Assessing and Treating Conduct Problems in Youth

Abstract

Conduct problems can be formally classified as “disruptive behavior disorders” which include conduct disorder (CD), oppositional defiant dis­order (ODD), and disruptive behavior disorder not otherwise specified (DBD-NOS) in the Diagnostic and Statistical Manual 4th edition (DSM-IV-TR; American Psychiatric Association, 2000). Conduct Disorder is a serious disorder which is characterized by persistent antisocial behavior and can be helpfully divided into early (before the age of 10 years) or late onset. Clinicians are often pessimistic about the effectiveness of treatment options available to manage CD and ODD; in particular, many are skeptical about the value of pharmacological treatments for managing CD and ODD, but is this skepticism justified?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Achenbach, T. M. (1991). Manual for the child behavior checklist/4–18 and 1991 profile. Burlington: University of Vermont, Department of Psychiatry.

    Google Scholar 

  • Allison, D. B., Mentore, J. L., Heo, M., et al. (1999). Antipsychotic induced weight gain a comprehensive research synthesis. American Journal of Psychiatry, 156, 416–432.

    Google Scholar 

  • Aman, M., De Smedt, G., Lyons, B., Findling, R., & Risperidone Disruptive Behavior Study Group. (2002). Double –blind, placebo-controlled study of risperidone for the treatment of disruptive behaviours in children with subaverage intelligence. American Journal of Psychiatry, 159, 1337–1346.

    Article  Google Scholar 

  • Aman, M. G., Singh, N., Stewart, A. W., & Field, C. J. (1985). Psychometric characteristics of the Abberrant Behavior Checklist. American Journal of Mental Deficiency, 89, 492–502.

    PubMed  Google Scholar 

  • Aman, M. G., Tasse, M., Rojahn, J., & Hammer, D. (1996). The Nisonger CBRF: a child behavior rating form for children with developmental disabilities. Research in Developmental Disability, 17, 41–57.

    Article  Google Scholar 

  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: American Psychiatric Association.

    Book  Google Scholar 

  • Armenteros, J. L., & Lewis, J. E. (2002). Citalopram treatment for impulsive aggression in children and adolescents: an open pilot study. Journal of American Academy of Child and Adolescent Psychiatry, 41(5), 522–529.

    Article  Google Scholar 

  • Banaschewski, T., Coghill, D., Santosh, P., et al. (2006). Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. European Journal of Child and Adolescent Psychiatry, 15(8), 476–495.

    Article  Google Scholar 

  • Bangs, M., Hazell, P., Danckaerts, M., Hoare, P., Coghill, D., Wehmeier, P., et al. (2006). Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics, 121, e314–e320.

    Article  PubMed  Google Scholar 

  • Barker, P., & Fraser, I. (1968). A controlled trial of haloperidol, in children. British Journal of Psychiatry, 114, 855–857.

    Article  PubMed  Google Scholar 

  • Caldwell, M., Maltereer, M., Umstead, D., & McCormick, D. (2008). A retrospective evaluation of adjunctive risperidone treatment in severely behaviourally disordered boys receiving psychosocial treatment. Journal of Child and Adolescent Psychopharmacology, 18(1), 34–43.

    Article  PubMed  Google Scholar 

  • Campbell, M., Adams, P., Small, A., Kafantaris, V., Silva, R., Shell, S., et al. (1995). Lithium in hospitalized aggressive children with conduct disorder: a double blind and placebo controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 34(4), 445–453.

    Article  PubMed  Google Scholar 

  • Campbell, M., Small, A., Green, W., Jennops, S., Perry, R., Bennett, W., et al. (1984). Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalised aggressive children with conduct disorder. Archives of General Psychiatry, 41, 650–656.

    Article  PubMed  Google Scholar 

  • Campbell, M., Silva, R., Kafantaris, V., Locasio, J., Gonzalez, N., Lee, D., et al. (1991). Predictors of side-effects associated with Lithium administration in children. Psychopharmacology Bulletin, 27(3), 373–380.

    PubMed  Google Scholar 

  • Cipriani, A., Barbui, C., & Geddes, J. (2005). Suicide, depression and antidepressants. British Medical Journal, 330, 373–374.

    Article  PubMed  Google Scholar 

  • Conners, C. (1998). Manual for Conners’ Rating Scale. Toronto: Multi- health care systems.

    Google Scholar 

  • Connor, D., Glatt, S., Lopez, I., Jackson, D., & Melloni, R. (2002). Psychopharmacology and aggression I: a meta-analysis of stimulant effects on overt/covert aggression-related behaviours in ADHD. Journal of American Academy of Child and Adolescent Psychiatry, 41(3), 253–261.

    Article  Google Scholar 

  • Croonenberghs, J., Fegert, J.M., Findling, R., De Smedt, G., Van Dongen, R., & Risperidone disruptive behaviour study group. (2005). Risperidone in children with disruptive behaviour disorders and subaverage intelligence: a 1 year open label study of 504 patients. Journal of American Academy of Child and Adolescent Psychiatry, 44, 67–72.

    Google Scholar 

  • Cueva, J., Overall, J., Small, A., Armenteros, J., Perry, R., & Campbell, M. (1996). Carbamazepine in aggressive children with Conduct Disorder: a double blind and placebo controlled study. Journal of American Academy of Child and Adolescent Psychiatry, 35(4), 480–490.

    Article  Google Scholar 

  • Cunningham, M. A., Pillai, V., & Blachford-Rogers, W. J. (1968). Haloperidol in the treatment of children with severe behaviour disorders. British Journal of Psychiatry, 144, 845–854.

    Article  Google Scholar 

  • Curtiss, G., Rosenthal, R., Marohn, R., Ostrar, E., Offer, D., & Trujillo, J. (1983). Measuring delinquent behaviour in inpatient treatment settings: revision and validation of the adolescent antisocial behavior checklist. Journal of American Academy of Child Psychiatry, 22, 459–466.

    Article  Google Scholar 

  • Deltito, J. A., Leviton, J., Damone, J., Hajal, F., & Zamberiedetti, M. (1998). Naturalistic experience with the use of divalproex sodium on an inpatient unit for psychiatric patients. Acta Psychiatrica Scandinavica, 97(3), 236–240.

    Article  PubMed  Google Scholar 

  • Derogatis, L. R., Lipman, R. S., & Covi, L. (1973). SCL-90: an outpatient psychiatric rating scale- preliminary report. Psychopharmacology Bulletin, 9, 13–28.

    PubMed  Google Scholar 

  • Donovan, S., Stewart, J., Nunes, E., Quitkin, F., Porides, M., Daniel, W., et al. (2000). Divalproex Treatment for youth with explosive temper and mood lability: a double blind, placebo controlled crossover design. American Journal of Psychiatry, 157, 812–820.

    Article  Google Scholar 

  • Donovan, S., Susser, E., Nunes, E., Stewart, J., Quitkin, F., & Klein, D. (1997). Divalproex treatment of disruptive adolescents: a report of 10 cases. Journal of Clinical Psychiatry, 58, 12–15.

    Article  PubMed  Google Scholar 

  • Findling, R. (2008). Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents. Journal of Clinical Psychiatry, 69(suppl 4), 9–14.

    PubMed  Google Scholar 

  • Findling, R., McNamara, N., Branicky, L., Schluchter, M., Lemon, E., & Blumer, J. (2000). A double–blind pilot study of risperidone in the treatment of conduct disorder. Journal of American Academy of Child and Adolescent Psychiatry, 39(4), 509–516.

    Article  Google Scholar 

  • Findling, R., Reed, M., O’Riordan, M., Demeter, C., Stansbrey, R., & McNamara, N. (2006). Effectiveness, sifter and pharmacokinetics of quetiapine in aggressive children with conduct disorder. Journal of American Academy of Child and Adolescent Psychiatry, 45(7), 792–800.

    Article  Google Scholar 

  • Greene, R., & Ablon, S. (2003). Treating explosive kids: the collaborative problem-solving approach. New York: The Guildford Press.

    Google Scholar 

  • Greenhill, L., Soloman, M., Pleak, R., & Ambrosini, P. (1985). Molindone hydrochloride treatment of hospitalised children with conduct disorder. Journal of Clinical Psychiatry, 46(8), 20–25.

    PubMed  Google Scholar 

  • Guy, W. (1976). ECDEU. Assessment for Psychopharmacology. Rockville: National Institute of Mental Health.

    Google Scholar 

  • Handen, D., & Hardan, A. (2006). Open-label prospective trial of olanzapine in adolescents with sub average intelligence and disruptive behavior disorders. Journal of American Academy of Child and Adolescent Psychiatry, 45(8), 928–935.

    Article  Google Scholar 

  • Hazell, P., & Stuart, J. (2003). A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. Journal of American Academy of Child and Adolescent Psychiatry, 42(8), 886–894.

    Article  Google Scholar 

  • Henggeler, S. W., Schoenwald, S. K., Borduin, C. M., Rowland, M. D., & Cunningham, P. B. (1998). Multisystemic treatment of antisocial behaviour in children and adolescents. New York: Guildford Press.

    Google Scholar 

  • Jefferson, J. (1982). The use of lithium in childhood and adolescence: an overview. Journal of Clinical Psychiatry, 43(5), 174–177.

    PubMed  Google Scholar 

  • Kafantaris, V., Campbell, M., Padron-Gayol, M., Small, A., Locascio, J., & Rosenberg, C. (1992). Carbamazepine in hospitalized aggressive conduct disordered children: an open pilot study. Psychopharmacology Bulletin, 28(2), 193–199.

    PubMed  Google Scholar 

  • Kaplan, S., Busner, J., Kupietz, S., Wasserman, E., & Segal, B. (1990). Effects of methylphenidate on adolescents with aggressive conduct disorder and ADHD: a preliminary report. Journal of American Academy of Child and Adolescent Psychiatry, 29(5), 719–723.

    Article  Google Scholar 

  • Kaplan, S., Heiligenstein, J., West, S., Busner, J., Harder, D., Dittman, R., et al. (2004). Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder. Journal of Attention Disorders, 8, 45–52.

    Article  PubMed  Google Scholar 

  • Kemph, J. P., Devane, C. L., Levin, C. M., Jarecke, M., & Millar, R. (1993). Treatment of aggressive children with clonidine, results of an open pilot study. Journal of American Academy of Child and Adolescent Psychiatry, 32, 577–581.

    Article  Google Scholar 

  • Klein, R., Abikoff, H., Klass, E., Ganeles, D., Seese, L., & Pollack, S. (1997). Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Archives of General Psychiatry, 54, 1073–1080.

    Article  PubMed  Google Scholar 

  • Kolko, D., Bukstein, O., & Barron, J. (1999). Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings. Journal of American Academy of Child and Adolescent Psychiatry, 38(5), 578–586.

    Article  Google Scholar 

  • McNair, D. M., Lorr, M., & Droppleman, L. F. (1971). Profile of mood states manual. San Diego: Educational Industrial Testing Service.

    Google Scholar 

  • Malone, R. P., Luebbert, R. P., Penea-Areit, M., Biesecker, K., & Delaney, M. A. (1994). The overt aggression scale in a study of lithium in aggressive conduct disorder. Psychopharmacology Bulletin, 30, 215–218.

    PubMed  Google Scholar 

  • Malone, R., Delaney, M. A., Luebbert, J., Carter, J., & Campbell, M. (2000). A double blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Archives of General Psychiatry, 57, 649–654.

    Article  PubMed  Google Scholar 

  • Masi, G., Milone, A., Canepa, G., Millepiedi, S., Mucci, M., & Muratari, F. (2006). Olanzapine treatment in adolescents with severe conduct disorder. European Psychiatry, 21, 51–57.

    Article  PubMed  Google Scholar 

  • Monroe, R. R. (1970). Episodic behavior disorders: a psychodynamic and neurophysiologic analysis. Cambridge Mass: Harvard University Press.

    Google Scholar 

  • Moretti, M., Emmrys, C., Grizenko, N., Holland, R., Moore, K., & Shamsie, J. (1997). The treatment of conduct disorder perspectives from across Canada. Canadian Journal of Psychiatry, 42, 637–648.

    Google Scholar 

  • Mozes, T., Meiri, G., Ben-Amity, G., Sabbagh, M., & Weizman, A. (2005). Reboxetine as an optional treatment for hyperkinetic conduct disorder: a prospective open-label trial. Journal of Child and Adolescent Psychopharmacology, 15(2), 259–269.

    Article  PubMed  Google Scholar 

  • Newcorn, J., Spencer, T., Biedeman, J., Milton, D., & Michelson, D. (2005). Atomoxetine treatment in children and adolescents with attention deficit/hyperactivity disorder and comorbid oppositional defiant disorder. Journal of American Academy of Child and Adolescent Psychiatry, 44(3), 240–248.

    Article  Google Scholar 

  • Pandina, G., Aman, M., & Findling, R. (2006). Risperidone in the management of disruptive behavior disorder. Journal of Child and Adolescent Psychopharmacology, 16, 379–392.

    Article  PubMed  Google Scholar 

  • Pandina, G., Bilder, R., Harvey, P., Keefe, R., Aman, M., & Gharabawi, G. (2007). Risperidone and cognitive function in children with disruptive behavior disorder. Biological Psychiatry, 62, 226–234.

    Article  PubMed  Google Scholar 

  • Pappadopulos, E., Wollston, S., Chait, A., Perks, M., Connor, D., & Jensen, P. (2006). Pharmacotherapy of aggression in children and adolescents: efficacy and effect size. Journal of Canadian Academy of Child and Adolescent Psychiatry, 15(1), 27–39.

    Google Scholar 

  • Petti, T. A., Fish, B., Shapiro, T., Cohen, I. L., & Campbell, M. (1982). Effects of chlordiazepoxide in disturbed children: a pilot study. Journal of Clinical Psychopharmacology, 2(4), 270–273.

    Article  PubMed  Google Scholar 

  • Platt, J., Campbell, M., Green, W., & Gregan, D. (1984). Cognitive effects of lithium carbonate and haloperidol in treatment-resistant aggressive children. Archives of General Psychiatry, 41, 657–662.

    Article  PubMed  Google Scholar 

  • Reyes, M., Buitelaar, J., Toran, P., Augustyns, I., & Erdekens, M. (2006). A randomized double-blind placebo controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders. American Journal of Psychiatry, 163(3), 402–410.

    Article  PubMed  Google Scholar 

  • Reyes, M., Croonenberghs, J., Augustyns, I., & Eerdekens, M. (2006). Long-term use of risperidone in children with disruptive behavior disorders and subaverage intelligence: efficacy, safety and tolerability. Journal of Child and Adolescent Psychopharmacology, 16(3), 260–272.

    Article  PubMed  Google Scholar 

  • Rifkin, A., Karajgi, B., Dicker, R., Peri, E., Boppana, V., Hasan, N., et al. (1997). Lithium treatment of conduct disorders in adolescents. American Journal of Psychiatry, 154(4), 554–555.

    PubMed  Google Scholar 

  • Robins, L., Tipp, J., & McEvoy, L. (1991). Antisocial personality. In L. Robins & D. Regier (Eds.), Psychiatric disorders in America (pp. 258–290). New York: New York Free Press.

    Google Scholar 

  • Snyder, R., Turgay, A., Aman, M., Binder, C., Fisman, S., Carroll, A., & the Risperidone Conduct Study Group. (2002). Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of American Academy of Child and Adolescent Psychiatry, 41(9), 1026–1036.

    Article  Google Scholar 

  • Soderstrom, H., Rastam, M., & Gillberg, C. (2002). A clinical case series of six extremely aggressive youths treated with olanzapine. European Child and Adolescent Psychiatry, 11, 138–141.

    Article  PubMed  Google Scholar 

  • Steiner, H., Petersen, M., Saxena, K., Ford, S., & Matthews, Z. (2003). Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial. Journal of Clinical Psychiatry, 64, 1183–1191.

    Article  PubMed  Google Scholar 

  • Swanson, J. (1992). School based Assessments and Interviews for ADD. Irvine: KC Publishing.

    Google Scholar 

  • Van Bellinghen, M., & de Troch, C. (2001). Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double blind, placebo-controlled pilot trial. Journal of Child and Adolescent Psychopharmacology, 11(1), 5–13.

    Article  PubMed  Google Scholar 

  • Weinberger, D. A. (1997). Distress and self-restraint as measures of adjustment across the life span: confirmatory factor analysis in clinical and non-clinical samples. Psychological Assessment, 9, 132–135.

    Article  Google Scholar 

  • Yudofsky, S. C., Silver, J. M., Jackson, W., Endicott, J., & Williams, D. (1986). The overt aggression scale for the objective rating of verbal and physical aggression. American Journal of Psychiatry, 143, 35–39.

    PubMed  Google Scholar 

  • Zubieta, J., & Alessi, N. (1992). Acute and chronic administration of trazadone in the treatment of disruptive behavior disorders in children. Journal of Clinical Psychopharmacology, 12(6), 346–351.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Dundee, Dundee, Scotland

    Helen L. Smith & David R. Coghill

Authors
  1. Helen L. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David R. Coghill
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Royal North Shore Hospital, Health Psychology Unit, University of Technology Sydney, St. Leonards, Sydney, 2065, New South Wales, Australia

    Rachael C. Murrihy

  2. Royal North Shore Hospital, Health Psychology Unit, University of Technology Sydney, St. Leonards, Sydney, 2065, New South Wales, Australia

    Antony D. Kidman

  3. Child Study Center, Department of Psychology, Virginia Tech, Blacksburg, 24060, Virginia, USA

    Thomas H. Ollendick

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer New York

About this chapter

Cite this chapter

Smith, H.L., Coghill, D.R. (2011). Pharmacotherapy for Children and Adolescents with Conduct Problems. In: Murrihy, R., Kidman, A., Ollendick, T. (eds) Clinical Handbook of Assessing and Treating Conduct Problems in Youth. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6297-3_15

Download citation

Publish with us

Policies and ethics

Search

Navigation